1. Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety;Goetz;IJC Heart Vascul.,2023
2. G. Goetz, B. Wernly, Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022. Decision Support Document 103/ 2. Update 2022.: 2022 [cited 24.10.2022]. Available from: https://eprints.aihta.at/1407/.
3. Anxiety, depression and quality of life in acute high-risk cardiac disease patients eligible for wearable cardioverter defibrillator: Results from the prospective multicenter CREDregistry;Weiss;PLoS ONE,2019
4. Institute of Health Economics (IHE), Quality Appraisal Checklist for Case Series [cited 01.07.2022]. Available from: https://www.ihe.ca/research-programs/rmd/cssqac/cssqac-about, 2016.
5. GRADE guidelines: 3. Rating the quality of evidence;Balshem;J. Clin. Epidemiol.,2011